Zacks Investment Research on MSN
SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits
Sight Sciences SGHT recently announced the publication of a systematic literature review and meta-analysis in the European ...
Economic analyses indicate OMNI is cost-effective compared to the market leader, iStent inject ®.
Background Sudden cardiac death (SCD) is a common cause of cardiovascular mortality, often triggered by ventricular ...
Patients taking Janus kinase (JAK) inhibitors for immune-mediated inflammatory diseases (IMIDs) face no greater risk of ...
The time to onset of action was fastest with IL-17 inhibitors, followed by IL-23, IL-12/23, then PDE-4 and JAK inhibitors for ...
CAR T-cell therapy carried a risk of second primary malignancy (SPM) that was no worse than that of other standard-of-care (SOC) cancer therapies, according to a systematic literature review and ...
Objective A systematic review, meta-analysis and meta-regression were performed on selected studies to investigate the incidence of atrial fibrillation (AF) among athletes compared with non-athlete ...
Correspondence to Dr Haruki Momma, Department of Medicine and Science in Sports and Exercise, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan; h-momma{at}med.tohoku.ac.jp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results